Items where Division is "Health Economics" and Year is 2023

Group by: Creators | Item Type | No Grouping
Jump to: B | M | S | T
Number of items: 5.

B

Brar, Sehr and Kaur, Gunjeet and Malaisamy, Muniyandi and Nagarajan, Karikalan and Bano, Henna and Bhansali, Anil and Jain, Sanjay and Kumari, Savita and Prinja, Shankar (2023) Cost of screening, out-of-pocket expenditure & quality of life for diabetes & hypertension in India. Cost of screening, out-of-pocket expenditure & quality of life for diabetes & hypertension in India, 157(6) (498-50). pp. 1-14.

M

Malaisamy, Muniyandi (2023) Families affected by catastrophic costs due to tuberculosis. Families affected by catastrophic costs due to tuberculosis, 10 (11). e1492-e1493.

Malaisamy, Muniyandi and Ramesh, PM and Wells, WA and Alavadi, Umesh (2023) The Cost-Effectiveness of the BEAT-TB Regimen for Pre-Extensively Drug-Resistant TB. The Cost-Effectiveness of the BEAT-TB Regimen for Pre-Extensively Drug-Resistant TB, 8 (411). pp. 1-10.

S

Singh, Meenu and Bhatia, Ragini and Devaraju, Madhuri and Ghuman, Malkeet Singh and Malaisamy, Muniyandi and Chauhan, Anil and Kaur, Kulbir and Rana, Monika and Pradhan, Pranita and Saini, Shivani (2023) Cost‑Effectiveness of TrueNat as Compared to GeneXpert as a Diagnostic Tool for Diagnosis of Pediatric Tuberculosis/MDR Tuberculosis under the National Tuberculosis Elimination Program of India. Diagnostic Tool for Diagnosis of Pediatric Tuberculosis/MDR Tuberculosis under the National Tuberculosis Elimination Program of India, 48 (1). pp. 24-30.

T

Thiruvengadam, Kannan and Krishnan, Rajendran and Malaisamy, Muniyandi (2023) The Prevalence of Self-Reported Tuberculosis in the Andaman and Nicobar Islands, India: Evidence from the NFHS-IV and V. The Prevalence of Self-Reported Tuberculosis in the Andaman and Nicobar Islands, India: Evidence from the NFHS-IV and V, 8 (464). pp. 1-10.

This list was generated on Wed May 1 16:00:55 2024 UTC.